Literature DB >> 20132468

Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson's subject mitochondrial transfer.

A Raquel Esteves1, Jane Lu, Mariana Rodova, Isaac Onyango, E Lezi, Richard Dubinsky, Kelly E Lyons, Rajesh Pahwa, Jeffrey M Burns, Sandra M Cardoso, Russell H Swerdlow.   

Abstract

Parkinson's disease (PD) is associated with perturbed mitochondrial function. Studies of cytoplasmic hybrid (cybrid) cell lines containing mitochondria from PD subjects suggest complex I dysfunction in particular is a relatively upstream biochemical defect. To evaluate potential downstream consequences of PD mitochondrial dysfunction, we used a cybrid approach to model PD mitochondrial dysfunction; our cybrid cell lines were generated via transfer of PD or control subject platelet mitochondria to mtDNA-depleted NT2 cells. To confirm our PD cybrid mitochondria did indeed differ from control cybrid mitochondria we measured complex I V(max) activities. Consistent with other PD cybrid reports, relative to control cybrid cell lines the PD cybrid cell line mean complex I V(max) activity was reduced. In this validated model, we used an oxygen electrode to characterize PD cybrid mitochondrial respiration. Although whole cell basal oxygen consumption was comparable between the PD and control cybrid groups, the proton leak was increased and maximum respiratory capacity was decreased in the PD cybrids. PD cybrids also had reduced SIRT1 phosphorylation, reduced peroxisome proliferator-activated receptor-gamma coactivator-1alpha levels, and increased NF-kB activation. We conclude mitochondrial respiration and pathways influenced by aerobic metabolism are altered in NT2 cybrid cell lines generated through transfer of PD subject platelet mitochondria.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20132468     DOI: 10.1111/j.1471-4159.2010.06631.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  32 in total

1.  The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm.

Authors:  A R Esteves; M G-Fernandes; D Santos; C Januário; S M Cardoso
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

2.  Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.

Authors:  Xue Xue; Song You; Qiang Zhang; Yan Wu; Guo-Zhang Zou; Paul C Wang; Yu-Liang Zhao; Yan Xu; Lee Jia; Xiaoning Zhang; Xing-Jie Liang
Journal:  Mol Pharm       Date:  2012-02-13       Impact factor: 4.939

Review 3.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

4.  Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.

Authors:  Venkatramanujam Srinivasan; Daniel P Cardinali; Uddanapalli S Srinivasan; Charanjit Kaur; Gregory M Brown; D Warren Spence; Rüdiger Hardeland; Seithikurippu R Pandi-Perumal
Journal:  Ther Adv Neurol Disord       Date:  2011-09       Impact factor: 6.570

5.  Sustained O-GlcNAcylation reprograms mitochondrial function to regulate energy metabolism.

Authors:  Ee Phie Tan; Steven R McGreal; Stefan Graw; Robert Tessman; Scott J Koppel; Pramod Dhakal; Zhen Zhang; Miranda Machacek; Natasha E Zachara; Devin C Koestler; Kenneth R Peterson; John P Thyfault; Russell H Swerdlow; Partha Krishnamurthy; Luciano DiTacchio; Udayan Apte; Chad Slawson
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

6.  Exercise increases mitochondrial complex I activity and DRP1 expression in the brains of aged mice.

Authors:  Aaron M Gusdon; Jason Callio; Giovanna Distefano; Robert M O'Doherty; Bret H Goodpaster; Paul M Coen; Charleen T Chu
Journal:  Exp Gerontol       Date:  2017-01-18       Impact factor: 4.032

7.  The second genome: Effects of the mitochondrial genome on cancer progression.

Authors:  Adam D Scheid; Thomas C Beadnell; Danny R Welch
Journal:  Adv Cancer Res       Date:  2019-02-27       Impact factor: 6.242

8.  A cybrid cell model for the assessment of the link between mitochondrial deficits and sporadic Parkinson's disease.

Authors:  Daniela M Arduíno; A Raquel Esteves; Russell H Swerdlow; Sandra M Cardoso
Journal:  Methods Mol Biol       Date:  2015

Review 9.  Mitochondria in neurodegeneration.

Authors:  E Lezi; Russell H Swerdlow
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

10.  Altered expression of SIRT gene family in head and neck squamous cell carcinoma.

Authors:  Chi-Chih Lai; Pai-Mei Lin; Sheng-Fung Lin; Cheng-Hsien Hsu; Hsin-Ching Lin; Ming-Luen Hu; Cheng-Ming Hsu; Ming-Yu Yang
Journal:  Tumour Biol       Date:  2013-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.